Form 8-K - Current report:
SEC Accession No. 0001193125-21-266663
Filing Date
2021-09-07
Accepted
2021-09-07 16:35:03
Documents
16
Period of Report
2021-09-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d331079d8k.htm   iXBRL 8-K 29053
2 EX-10.1 d331079dex101.htm EX-10.1 19741
3 EX-10.2 d331079dex102.htm EX-10.2 15055
4 EX-99.1 d331079dex991.htm EX-99.1 12585
8 GRAPHIC g331079g0907235946313.jpg GRAPHIC 2718
  Complete submission text file 0001193125-21-266663.txt   220896

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA alec-20210907.xsd EX-101.SCH 2876
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE alec-20210907_lab.xml EX-101.LAB 18138
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alec-20210907_pre.xml EX-101.PRE 11397
9 EXTRACTED XBRL INSTANCE DOCUMENT d331079d8k_htm.xml XML 3332
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 211239717
SIC: 2836 Biological Products, (No Diagnostic Substances)